Joel Greenblatt Gotham Asset Management
Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BILL Holdings
BILL
|
+$41.5M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$35.9M |
| 3 |
Gotham Enhanced 500 ETF
GSPY
|
+$35.8M |
| 4 |
PayPal
PYPL
|
+$17.4M |
| 5 |
NATI
National Instruments Corp
NATI
|
+$12.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$14M |
| 2 |
Lam Research
LRCX
|
+$12.7M |
| 3 |
Meta Platforms (Facebook)
META
|
+$9.54M |
| 4 |
VMW
VMware, Inc
VMW
|
+$9.3M |
| 5 |
Valvoline
VVV
|
+$9.03M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.4% |
| 2 | Industrials | 12.68% |
| 3 | Consumer Discretionary | 10.55% |
| 4 | Healthcare | 8.73% |
| 5 | Financials | 6.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Seagate
STX
$193B
| $3.87M | 0.07% |
45,288
-41,392
| -48% | -$3.09M |
|
377
Wolfspeed
WOLF
$1.34B
| $3.86M | 0.07% |
88,757
+32,609
| +58% | +$1.18M |
|
378
EnerSys
ENS
$6.84B
| $3.86M | 0.07% |
38,208
+4,255
| +13% | +$391K |
|
379
EOG Resources
EOG
$80.3B
| $3.86M | 0.07% |
31,893
-23,450
| -42% | -$2.92M |
|
380
Texas Instruments
TXN
$241B
| $3.83M | 0.07% |
22,462
+11,492
| +105% | +$1.78M |
|
381
SLB Ltd
SLB
$79.9B
| $3.83M | 0.07% |
73,567
+4,496
| +7% | +$244K |
|
382
Hershey
HSY
$37.5B
| $3.82M | 0.07% |
20,497
+15,834
| +340% | +$3M |
|
383
C.H. Robinson
CHRW
$16.5B
| $3.8M | 0.07% |
43,970
-71,542
| -62% | -$6M |
|
|
AL
384
DELISTED
Air Lease Corp
AL
| $3.78M | 0.07% |
90,231
+3,242
| +4% | +$123K |
|
385
Analog Devices
ADI
$182B
| $3.76M | 0.07% |
18,919
-1,781
| -9% | -$318K |
|
386
Aramark
ARMK
$15.8B
| $3.76M | 0.07% |
133,634
+74,224
| +125% | +$2.01M |
|
|
HHGC
387
DELISTED
HHG Capital Corporation Ordinary Shares
HHGC
| $3.75M | 0.07% |
43,860
-7,064
| -14% | -$80K |
|
388
Exelixis
EXEL
$13.4B
| $3.75M | 0.07% |
156,395
+8,088
| +5% | +$176K |
|
389
Nike
NKE
$60.5B
| $3.75M | 0.07% |
34,507
-623
| -2% | -$66.9K |
|
390
Chemours
CC
$2.4B
| $3.73M | 0.07% |
118,190
+75,454
| +177% | +$2.05M |
|
391
CONMED
CNMD
$1.53B
| $3.73M | 0.07% |
34,019
+10,558
| +45% | +$1.09M |
|
392
Boston Beer
SAM
$1.91B
| $3.72M | 0.07% |
10,751
+1,305
| +14% | +$458K |
|
393
Newmont
NEM
$139B
| $3.71M | 0.07% |
89,564
+21,449
| +31% | +$828K |
|
394
TechnipFMC
FTI
$30.4B
| $3.65M | 0.07% |
181,168
+160,297
| +768% | +$3.28M |
|
395
Celsius Holdings
CELH
$8.44B
| $3.64M | 0.07% |
66,701
-11,308
| -14% | -$604K |
|
396
Cognex
CGNX
$10.2B
| $3.63M | 0.07% |
87,028
+50,079
| +136% | +$1.92M |
|
397
Manhattan Associates
MANH
$12.5B
| $3.62M | 0.07% |
16,835
+6,789
| +68% | +$1.44M |
|
398
Cummins
CMI
$80.9B
| $3.62M | 0.07% |
+15,130
| New | +$3.44M |
|
399
Halozyme
HALO
$12.3B
| $3.62M | 0.07% |
97,888
+55,782
| +132% | +$2.1M |
|
400
Roku
ROKU
$23.4B
| $3.57M | 0.07% |
38,974
-2,154
| -5% | -$180K |
|
Similar funds
Joel Greenblatt's Q4 2023 Portfolio in Review
As of Q4 2023, Joel Greenblatt held 1,470 positions worth $5.39B, up 11% from $4.84B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Joel Greenblatt's Q4 2023 filing shows 157 new, 492 increased, 650 reduced and 145 closed positions. Its largest new stake was Fidelity Fundamental Small-Mid Cap ETF: 457,078 shares worth $4.99M. The largest sale was Pfizer, an estimated $14M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Industrials and Consumer Discretionary.
- Joel Greenblatt's largest Q4 2023 buy was Fidelity Fundamental Small-Mid Cap ETF: 457,078 shares worth $4.99M.
- Joel Greenblatt added most to BILL Holdings in Q4 2023, an estimated $41.5M increase.
- Joel Greenblatt's biggest Q4 2023 reduction was Pfizer, cutting an estimated $14M.
- Joel Greenblatt fully exited VMware, Inc in Q4 2023, selling an estimated $9.3M.
- Joel Greenblatt's ten largest holdings make up 24% of its $5.39B portfolio in Q4 2023.
- Joel Greenblatt opened 157 new positions and closed 145 in Q4 2023.
- Joel Greenblatt's portfolio value rose 11% quarter-over-quarter to $5.39B.
Based on Gotham Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.